Literature DB >> 1425715

Treatment of tularemia with ciprofloxacin.

O Scheel1, R Reiersen, T Hoel.   

Abstract

A case of tularemia which occurred after close contact with a cat is presented. After unsuccessful amoxicillin treatment, a two-week course of doxycycline was given whereupon the patient responded well. However, the patient relapsed shortly after and was then given ciprofloxacin for two weeks. The patient then recovered completely. Clinical trials are needed in order to establish whether a quinolone could be the drug of choice for treatment of tularemia.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1425715     DOI： 10.1007/bf01961860

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

1.  Pleuropulmonary tularemia: successful treatment with erythromycin.

Authors:  R E Harrell; H F Simmons
Journal:  South Med J       Date:  1990-11       Impact factor: 0.954

2.  An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics.

Authors:  E L OVERHOLT; W D TIGERTT; P J KADULL; M K WARD; N D CHARKES; R M RENE; T E SALZMAN; M STEPHENS
Journal:  Am J Med       Date:  1961-05       Impact factor: 4.965

3.  Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.

Authors:  R Lang; R Raz; T Sacks; M Shapiro
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

Review 4.  Tularemia: a 30-year experience with 88 cases.

Authors:  M E Evans; D W Gregory; W Schaffner; Z A McGee
Journal:  Medicine (Baltimore)       Date:  1985-07       Impact factor: 1.889

5.  Isolation of Francisella tularensis from blood.

Authors:  J M Provenza; S A Klotz; R L Penn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Tularemia pneumonia mimicking legionnaires' disease: isolation of organism on CYE agar and successful treatment with erythromycin.

Authors:  E L Westerman; J McDonald
Journal:  South Med J       Date:  1983-09       Impact factor: 0.954

7.  Infraspecific taxonomy of tularemia agent Francisella tularensis McCoy et Chapin.

Authors:  N G Olsufjev; I S Meshcheryakova
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1982

8.  In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.

Authors:  H Syrjälä; R Schildt; S Räisäinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

9.  Isolation of Francisella tularensis biovar palaearctica from human blood.

Authors:  A Tärnvik; C Henning; E Falsen; G Sandström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

10.  Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.

Authors:  C N Baker; D G Hollis; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948
View more
  12 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Tularemia in Bursa, Turkey: 205 cases in ten years.

Authors:  S Helvaci; S Gedikoğlu; H Akalin; H B Oral
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

3.  Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds.

Authors:  Elamparithi Jayamani; Nagendran Tharmalingam; Rajmohan Rajamuthiah; Jeffrey J Coleman; Wooseong Kim; Ikechukwu Okoli; Ana M Hernandez; Kiho Lee; Gerard J Nau; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  Bactericidal activities of antibiotics against intracellular Francisella tularensis.

Authors:  M Maurin; N F Mersali; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

5.  Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.

Authors:  Marjorie D Sutherland; Andrew W Goodyear; Ryan M Troyer; Jeffrey C Chandler; Steven W Dow; John T Belisle
Journal:  Vaccine       Date:  2012-05-28       Impact factor: 3.641

Review 6.  Quinolones in intracellular infections.

Authors:  J C Pechère
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Tularemia in children.

Authors:  Solmaz Celebi; Mustafa Hacimustafaoglu; Suna Gedikoglu
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

8.  Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.

Authors:  Shahar Rotem; Erez Bar-Haim; Hila Cohen; Uri Elia; Raphael Ber; Avigdor Shafferman; Ofer Cohen
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

9.  Resistance of Francisella novicida to fosmidomycin associated with mutations in the glycerol-3-phosphate transporter.

Authors:  Ryan S Mackie; Elizabeth S McKenney; Monique L van Hoek
Journal:  Front Microbiol       Date:  2012-08-09       Impact factor: 5.640

10.  The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden.

Authors:  Henrik Eliasson; Johan Lindbäck; J Pekka Nuorti; Malin Arneborn; Johan Giesecke; Anders Tegnell
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.